Navigation Links
Testing for blood sugar levels made easier

The foundation of diabetics care is the regular monitoring of blood sugar levels. But doctors say that many patients do not adhere to this routine because of inconvenience or discomfort, as this requires multiple blood samples to be taken by puncturing// their fingers or forearm. However, researchers from University of Texas have discovered a new non-invasive test, using optical coherence tomography, which will end the pain of pricking for diabetes patients.

Optical Coherence Tomography uses advanced photonics and fiber optics to obtain images of tissues. It uses infrared light waves that reflect off the internal structures within tissues to send back a picture and information about the tissue, in this case, including blood sugar levels.

A pilot study of OCT was done on 15 healthy volunteers when images of the left forearm were taken every 10 to 20 seconds for over three hours. Doctors took 420 blood glucose measurements from the volunteers using blood analysis for comparison. They also recorded 8,435 OCT images.

Researchers at the end of the pilot study concluded that OCT was an effective non-invasive, real-time, sensitive monitoring technique for assessment of blood glucose concentration in human subjects during an OGTT (oral glucose tolerance test). The high quality resolution of images and accuracy are the advantages of the OCT approach, which needs more studies to validate the results.


'"/>




Page: 1

Related medicine news :

1. First Vaccine Designed for Africa Cleared for Testing in Humans
2. Laboratory Testing Can Identify Risk of Pre-Term Labor and Delivery
3. DNA Testing For More Accurate Results
4. SARS vaccine shows promise in Animal Testing
5. Testing Of Saliva May Predict Dental Caries
6. Diagnosing Sleep Apnea By Overnight Sleep Testing Method
7. Testing genes for disease does not cause harm to children of people with Alzheimers
8. Testing Your Health & Charging Your Mobile At One Go - Check Out The Urine Powered Batteries
9. Testing For HIV/AIDS Compulsory For New Military Recruits
10. Japanese And Chinese Pharmaceutical Companies Join Together In Drug Testing
11. Eye Diseases Diagnosed Through Genetical Testing
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/22/2017)... , ... February 22, 2017 , ... A product of ... seem to derive a heart-protective benefit from eating soy foods, while others do not, ... men who are able to produce equol—a substance made by some types of “good” ...
(Date:2/22/2017)... ... February 22, 2017 , ... Forty-five percent ... those report that family members or friends have also commented about their poor ... loss wear hearing aids. One reason, suggested by 89 percent of American respondents, ...
(Date:2/22/2017)... , ... February 22, 2017 , ... Super-Sod will attend ... 26 event in Athens, Georgia. , A shift from Super-Sod’s simple Athens Home Show ... , For the booth, grass seed plant manager Chris Roquemore constructed furniture from recycled ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Social media ... especially for hospitals and health systems. Smith & Jones’ delves into this insight and ... episode, President of Smith & Jones David Vener meets up with social media strategist ...
(Date:2/22/2017)... ... February 22, 2017 , ... BrightStar Care Charleston , a ... Medical University of South Carolina (MUSC) Center on Aging’s Senior Expo on Thursday, ... on Aging is a tremendous resource in our community. We are thrilled to participate ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... 2017 Research and Markets has announced ... (Thermometers - Digital, Infrared, Mercury; Trend Indicator):Analysis By Region, By Country ... ... forecasted to grow at a CAGR of 5.33% during 2016-2021 ... infectious diseases along with surging demand of digital thermometer. Apart from ...
(Date:2/22/2017)... Feb. 22, 2017 Oncternal Therapeutics, Inc., ... both rare and common malignancies, today announced the ... The company intends to use the proceeds to ... and to advance preclinical development of a new ... is a first-in-class anti-ROR1 monoclonal antibody being developed ...
(Date:2/22/2017)... -- Kineta, Inc., a biotechnology company focused on ... today announced that KCP-400 (RgIA4), a potent antagonist ... robust chronic pain relief and disease modifying effects ... the a9a10 nAChR as a new, non-opioid target ... were reported online in the February 20 th ...
Breaking Medicine Technology: